BRIEF published on 09/19/2025 at 18:05, 9 months 17 days ago Advicenne : Résultats semestriels en 2025 et perspectives Chiffre D'affaires Résultats Financiers Perspectives États-Unis Sibnayal®
PRESS RELEASE published on 09/19/2025 at 18:00, 9 months 17 days ago Informations privilégiées / Communiqué sur comptes, résultats Advicenne présente ses résultats financiers semestriels au 30 juin 2025 et fait le point sur ses activités. Augmentation du chiffre d'affaires et perspectives favorables avec Sibnayal® Résultats Financiers Croissance Perspectives Advicenne Sibnayal®
BRIEF published on 07/28/2025 at 07:35, 11 months 10 days ago Advicenne obtient l'autorisation de mise sur le marché de Sibnayal® en Arabie saoudite Arabie Saoudite Remboursement Advicenne ATRd Sibnayal®
BRIEF published on 07/28/2025 at 07:35, 11 months 10 days ago Advicenne Secures Marketing Authorization for Sibnayal® in Saudi Arabia Saudi Arabia Advicenne Reimbursement Sibnayal® DRTA
PRESS RELEASE published on 07/28/2025 at 07:30, 11 months 10 days ago Informations privilégiées / Autres communiqués Advicenne obtient l’AMM et le remboursement de Sibnayal en Arabie Saoudite pour le traitement des maladies rénales rares. Collaboration avec Taïba Healthcare Arabie Saoudite Advicenne Maladies Rénales Rares AMM Sibnayal
PRESS RELEASE published on 07/28/2025 at 07:30, 11 months 10 days ago Inside Information / Other news releases Advicenne obtains marketing authorization and reimbursement for Sibnayal® in Saudi Arabia, a fixed combination for rare kidney diseases, in collaboration with Taïba Healthcare Saudi Arabia Advicenne Reimbursement Marketing Authorization Sibnayal
BRIEF published on 07/25/2025 at 07:35, 11 months 13 days ago Advicenne Annonce une Croissance de 9% de son Chiffre d'Affaires pour le S1 2025 Chiffre D'affaires Croissance Advicenne Sibnayal® Marchés Pharmaceutiques
BRIEF published on 07/25/2025 at 07:35, 11 months 13 days ago Advicenne Announces 9% Revenue Growth for H1 2025 Growth Turnover Advicenna Sibnayal® Pharmaceutical Markets
PRESS RELEASE published on 07/25/2025 at 07:30, 11 months 13 days ago Inside Information / Other news releases Advicenne reports H1 2025 sales of €2.6 million, with direct sales rising 17% and Sibnayal® sales in Europe up 90% compared to H1 2024. Company's cash flow horizon extends to Q3 2026 Cash Flow Pharmaceutical Advicenne Sibnayal H1 2025 Sales
PRESS RELEASE published on 07/25/2025 at 07:30, 11 months 13 days ago Informations privilégiées / Autres communiqués Advicenne publie un chiffre d'affaires en hausse de 9% au S1 2025, avec des ventes de Sibnayal® en progression de 17%. La société dispose de trésorerie jusqu'au 3ème trimestre 2026 Chiffre D'affaires Trésorerie Advicenne S1 2025 Sibnayal®
Published on 07/07/2026 at 09:05, 2 hours 10 minutes ago HM Exploration Expands Newly Discovered Blind Massive Sulphide Lens at Lewis Pilley's Project
Published on 07/07/2026 at 09:01, 2 hours 14 minutes ago Star Copper Begins Step-Out Drilling at Star Main Location to Test Northeast Extension of Hypogene System
Published on 07/06/2026 at 23:32, 11 hours 43 minutes ago Marrelli Capital Limited - Early Warning Regarding Acquisition of Common Shares of BE Resources Inc.
Published on 07/06/2026 at 23:30, 11 hours 45 minutes ago 1742096 Ontario Ltd. - Early Warning Regarding Acquisition of Common Shares of BE Resources Inc.
Published on 07/06/2026 at 19:25, 15 hours 50 minutes ago Critical Elements Provides an Update on Its 10,000-Meter Summer Drill Program at Rose West
Published on 07/07/2026 at 11:00, 15 minutes ago GBC AG initiates coverage of MustGrow Biologics Corp. with a BUY rating, 'From mustard seed to scalable biologicals platform'
Published on 07/07/2026 at 10:09, 1 hour 5 minutes ago AUSTRIACARD Achieves World-First Published Visa 3.1 Approval for Next-Generation Payment Smart Card OS
Published on 07/07/2026 at 09:55, 1 hour 19 minutes ago PNE sells 10.8 MW “Romescamps” wind farm project in France
Published on 07/07/2026 at 09:54, 1 hour 21 minutes ago Tivoly Group launches two B2B commerce platforms on Intershop
Published on 07/07/2026 at 10:01, 1 hour 14 minutes ago Déclaration mensuelle du nombre total de droits de vote et du nombre d’actions composant le capital
Published on 07/06/2026 at 18:00, 17 hours 15 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 26 juin 2026
Published on 07/06/2026 at 18:00, 17 hours 15 minutes ago Information concerning the total number of voting rights and shares in the share capital as of June 26, 2026
Published on 07/06/2026 at 18:00, 17 hours 15 minutes ago LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 30 juin 2026
